Brian Rini, MD
@brian_rini
ID:2575325303
01-06-2014 13:10:15
1,6K Tweets
5,0K Followers
433 Following
ποΈ Brian Rini, MD and Tom Powles of the Uromigos spoke with Matt Galsky about the #OS signal data from #CheckMate274 , which analyzed the use of #adjuvant #nivolumab in patients with #MIBC .
π Listen Here: buff.ly/3JioJM6
π Don't miss our latest video with Katy Beckermann and Michael Atkins, MD, of Georgetown Lombardi, where they discuss LAG-3 With PD-1 in #KidneyCancer .
πΊ Watch Now: buff.ly/3U9ypi9
An exceptional Uromigos 2-part podcast on CM274 OS data presented by Matt Galsky & IMvigor010 ctDNA neg pts outcomes by Tom Powles
Scintillating discussion on biomarkers, ongoing trials (IMvigor011 & MODERN) & more! Must listen!
Brian Rini, MD
Check out the AKCI didactic video YouTube page for the latest lecture by Boyi Gan, PhD on ferroptosis targeting in RCC!
youtube.com/@AcademyofKidnβ¦
Top Influencers in GU Ocology by LARVOL
Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Petros Grivas Tom Powles Andrea Apolo, M.D. Matt Galsky Tian Zhang, MD, MHS Elizabeth Plimack MD Brian Rini, MD
oncodaily.com/43245.html
#Cancer #GUOncology #LARVOL #OncoDaily #Oncology
Part 2 of bladder sparing approaches in muscle invasive bladder cancer Michiel van der Heijden - new drugs, utDNA, ctDNA and radiotherapy could change everything. Will we need adjuvant therapy? podcasters.spotify.com/pod/show/the-uβ¦
This one doesnβt disappointβ©. Crushed a bit by β¦Matt Galskyβ© biomarker comment βif you know the future predicting the future isnβt helpfulβ β¦Tom Powlesβ© β¦β¦Brian Rini, MDβ© podcasts.apple.com/us/podcast/theβ¦
ποΈ #ICYMI : In the latest Uromigos episode, Brian Rini, MD and Tom Powles sat down with Tanya Dorff to discuss her work investigating #acapatamab , a #CD3 and #PSMA bispecific t-cell engaging antibody studied in advanced #ProstateCancer .
π Listen Here: buff.ly/4a5DqOw
π Don't miss episode 305 of the Uromigos with Brian Rini, MD and Tom Powles.
π In this edition, the Uromigos talk with FDA Oncology's Deputy Director Dan Suzman about #oncology trials, including approaches to control arms in phase 3 trials.
ποΈ Listen: buff.ly/3TvkAcw
ποΈ In the latest Uromigos episode, Brian Rini, MD and Tom Powles sat down with Tanya Dorff to discuss her work investigating #acapatamab , a #CD3 and #PSMA bispecific t-cell engaging antibody studied in advanced #ProstateCancer .
π Listen Here: buff.ly/4a5DqOw
Join us at the 2024 World Conference on GU cancers in New York this August. We look forward to hosting a Featured Session at this 2-day CE meeting and sharing the stage with world-renowned thought leaders. Register at: worldguconference.com World GU Conference #WorldGU24
Join me and @VUMChealthcolleagues Dr. Amy Luckenbaugh and Dr. Austin Kirschner as we share insights & innovations in treating #kidneycancer Vanderbilt-Ingram Cancer Center with anyone touched by #renalcancer . Wed 3/27, 1-2CT. Register here: VICCKidneyCancer.eventbrite.com
Vanderbilt University Medical Center
π ICYMI: In episode 303 of the Uromigos, Tom Powles and Brian Rini, MD sit down with Mike Lattanzi of Texas Oncology to discuss treatment plans and research in the community #GUOncology setting.
ποΈ Listen Now: buff.ly/43jCJP0
The OncoAlert π¨ Network is Proud to be collaborating with our friends at Advanced Prostate Cancer Consensus Conference Uromigos & our AMAZING Faculty
Register Here onlineevent.ch/APCCC/2024
Here is our friend & Colleague Brian Rini, MD πΊπΈ of Vanderbilt-Ingram Cancer Center & Co Host of Uromigos with a warm invitation toβ¦
π Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24 !
Join global experts in consensus discussions that shape future treatments.
ποΈ Register now for an unmissable experience: apccc.org
#Oncology #GU24 #oncoalert
WATCH: Brian Rini, MD, of Vanderbilt Health, discusses the research that led to the FDA approval of belzutifan for patients with advanced renal cell carcinoma. #kcsm onclive.com/view/dr-rini-oβ¦